Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d’arrhythmies cardiaques)-group

AIMS: Despite advances in interventional treatment strategies, atrial fibrillation (AF) remains associated with significant morbidity and mortality. Fibrotic atrial myopathy (FAM) is a main factor for adverse outcomes of AF-ablation, but complex to diagnose using current methods. We aimed to derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller-Edenborn, Björn, Moreno-Weidmann, Zoraida, Venier, Sandrine, Defaye, Pascale, Park, Chan-il, Guerra, José, Alonso-Martín, Concepcion, Bazan, Victor, Vinolas, Xavier, Rodriguez-Font, Enrique, Garcia, Bieito Campos, Boveda, Serge, Combes, Stéphane, Albenque, Jean-Paul, Guy-Moyat, Benoit, Trenk, Dietmar, Eichenlaub, Martin, Chen, Juan, Lehrmann, Heiko, Neumann, Franz-Josef, Arentz, Thomas, Jadidi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424172/
https://www.ncbi.nlm.nih.gov/pubmed/34854991
http://dx.doi.org/10.1007/s00392-021-01973-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424172/
https://www.ncbi.nlm.nih.gov/pubmed/34854991
http://dx.doi.org/10.1007/s00392-021-01973-1

Ejemplares similares